tiprankstipranks
Trending News
More News >
Soleno Therapeutics Inc (SLNO)
NASDAQ:SLNO
US Market

Soleno Therapeutics (SLNO) Income Statement

Compare
883 Followers

Soleno Therapeutics Income Statement

Last quarter (Q3 2025), Soleno Therapeutics's total revenue was $66.02M, an increase of Infinity% from the same quarter last year. In Q3, Soleno Therapeutics's net income was $26.01M. See Soleno Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -1.96M$ 0.00$ 0.00$ -2.19M
Operating Expenses
$ 187.67M$ 41.38M$ 24.40M$ 31.53M$ 29.75M
Depreciation and Amortization
$ 1.99M$ 1.96M$ 1.96M$ 1.96M$ 2.19M
EBITDA
$ -173.63M$ -37.03M$ -22.10M$ -30.30M$ -22.45M
Operating Income
$ -187.67M$ -41.38M$ -24.40M$ -31.53M$ -31.95M
Other Income/Expenses
$ 11.82M$ 2.40M$ 330.00K$ 618.00K$ 7.31M
Pretax Income
$ -175.85M$ -38.99M$ -24.07M$ -30.91M$ -24.64M
Net Income
$ -175.85M$ -38.99M$ -24.07M$ -30.91M$ -24.64M
Per Share Metrics
Basic EPS
$ -4.38$ -2.36$ -2.87$ -5.81$ -3.68
Diluted EPS
$ -4.38$ -2.36$ -2.87$ -5.81$ -3.68
Weighted Average Shares Outstanding
40.18M 16.49M 8.40M 5.32M 4.17M
Weighted Average Shares Outstanding (Diluted)
40.18M 16.49M 8.40M 5.32M 4.17M
Currency in USD

Soleno Therapeutics Earnings and Revenue History